Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Dr. Schweizer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014
University of ChicagoResidency, Internal Medicine, 2008 - 2011
Lewis Katz School of Medicine at Temple UniversityClass of 2008
Certifications & Licensure
WA State Medical License 2014 - 2027
AK State Medical License 2022 - 2026
MD State Medical License 2011 - 2015
IL State Medical License 2008 - 2011
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer Start of enrollment: 2020 Apr 27
- A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Start of enrollment: 2020 Feb 06
- A Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2019 Nov 22
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsNeoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer:...Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, Kelsey K Baker, Kevin Ng
European Urology. 2025-12-01 - Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort s...Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, Leonidas Ν Diamantopoulos, Dimitrios Makrakis
Urologic Oncology. 2025-12-01 - Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617.Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, Pedro C Barata, Mehmet Asim Bilen
The Oncologist. 2025-11-11
Journal Articles
- Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing InterferenceMichael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology
Press Mentions
Mevrometostat Combo Posts Strong Data in Early-Phase Prostate Cancer TrialFebruary 21st, 2025- Radiographic PFS in Metastatic CRPC More Than Doubles with Novel CombinationFebruary 13th, 2025
- Fred Hutch at ASCO: Progress in Treating Metastatic Cancer, Hospice Access for Cancer Patients, Use of Machine Learning with CAR T-cell TherapyMay 23rd, 2024
- Join now to see all
Grant Support
- Augmenting PSMA expression to enhance PSMA directed therapeutic efficacyFRED HUTCHINSON CANCER CENTER2024–2029
- Augmenting PSMA expression to enhance PSMA directed therapeutic efficacyFRED HUTCHINSON CANCER CENTER2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
